AMC
AMC Entertainment Holdings, Inc.
AMC offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
OPRA
Opera Limited
OPRA has the edge over AMC overall, supported by lower modeled downside and stronger valuation.
AMC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Stable | |
| Under pressure |
AMC's revenue is currently healthy, and its profitability and cash flow are stable, but its balance sheet is under pressure.
OPRA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Strong | |
| Strong |
OPRA's revenue, profitability, cash flow and balance sheet are all currently healthy.
AMC PE Valuation
AMC has no meaningful PE right now: it lost money over the past year.
OPRA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.4x | $10.24 | -35% |
| Current | 11x | $15.63 | — |
| Fair | 16x | $22.42 | +43% |
| Expensive | 28x | $38.34 | +145% |
Historical ranges are pointers, not guarantees.
OPRA's PE is in its cheap range at 11x, but its recent earnings include one-off gains.
AMC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect AMC's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
OPRA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for OPRA, with profitability improving.
AMC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.40 | +$0.94 |
| Q2 2026 | -$1.10 | -$0.28 |
| Q1 2026 | -$1.09 | -$0.18 |
| Q4 2025 | -$1.34 | -$0.28 |
| Q3 2025 | -$1.34 | +$0.29 |
| Q2 2025 | -$0.82 | +$0.67 |
| Q1 2025 | -$0.91 | +$0.38 |
| Q4 2024 | -$1.06 | +$1.31 |
AMC lost $0.40 per share over the past year, a smaller loss than the year before.
OPRA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $1.38 | +55% |
| Q1 2026 | $1.25 | +33% |
| Q4 2025 | $1.18 | +30% |
| Q4 2025 | $0.89 | -55% |
| Q2 2025 | $0.89 | -54% |
| Q1 2025 | $0.94 | -50% |
| Q4 2024 | $0.91 | -52% |
| Q3 2024 | $1.97 | +170% |
OPRA has the edge over AMC on earnings quality, reporting a profit while its opponent remains loss making.
AMC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.7B | +32% |
| Q2 2026 | $1.6B | +14% |
| Q1 2026 | $1B | +21% |
| Q4 2025 | $1.3B | -1.4% |
| Q3 2025 | $1.3B | -3.6% |
| Q2 2025 | $1.4B | +36% |
| Q1 2025 | $862.5M | -9.3% |
| Q4 2024 | $1.3B | +18% |
AMC's revenue is growing: $1.7B last quarter, up 32% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +12 points |
| Q2 2026 | 15% | +8.3 points |
| Q1 2026 | -4.4% | +13 points |
| Q4 2025 | 0% | -0.3 points |
| Q3 2025 | 2.8% | -2.6 points |
| Q2 2025 | 6.6% | +11 points |
| Q1 2025 | -17% | -5.5 points |
| Q4 2024 | 0.4% | +14 points |
AMC's operating margin was 15% last quarter, up 12 points from the same quarter a year ago, near the top of its range since 2019.
OPRA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $177.5M | +24% |
| Q1 2026 | $175.8M | +23% |
| Q4 2025 | $177M | +21% |
| Q4 2025 | $151.9M | +23% |
| Q2 2025 | $143M | +30% |
| Q1 2025 | $142.7M | +40% |
| Q4 2024 | $145.8M | +29% |
| Q3 2024 | $123.2M | +20% |
OPRA has the edge over AMC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 16% | +3.7 points |
| Q1 2026 | 17% | +2.5 points |
| Q4 2025 | 17% | -2.3 points |
| Q4 2025 | 15% | -4.1 points |
| Q2 2025 | 13% | -7.3 points |
| Q1 2025 | 15% | -4.4 points |
| Q4 2024 | 19% | +0.9 points |
| Q3 2024 | 19% | +3.2 points |
OPRA has the edge over AMC on profitability, with a higher operating margin.
AMC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $109.3M | +$190.4M |
| Q2 2026 | $190.1M | +114% |
| Q1 2026 | -$174.7M | +$242.3M |
| Q4 2025 | $43.3M | -62% |
| Q3 2025 | -$81.1M | +$11.1M |
| Q2 2025 | $88.9M | +$168.1M |
| Q1 2025 | -$417M | -$178.2M |
| Q4 2024 | $113.9M | +$263.8M |
AMC has the edge over OPRA on cash flow, with more consistent year-over-year improvement.
OPRA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $21.8M | -28% |
| Q1 2026 | $36.8M | +140% |
| Q4 2025 | $39.6M | +101% |
| Q4 2025 | $22.5M | -27% |
| Q2 2025 | $30.3M | +109% |
| Q1 2025 | $15.3M | +42% |
| Q4 2024 | $19.7M | -20% |
| Q3 2024 | $30.8M | +93% |
OPRA generated $121M in free cash flow over the past year, up 26% from the year before.
AMC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +24% | +175M shares |
| 1 year | +107% | +463M shares |
| 3 years | +767% | +793M shares |
| 5 years | +4063% | +875M shares |
AMC has 897M diluted shares, up 107% from a year ago.
OPRA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -67K shares |
| 1 year | +0.8% | +760K shares |
| 3 years | -0.3% | -237K shares |
| 5 years | -21% | -24.7M shares |
| Available history | -19% | -21.9M shares |
OPRA has the edge over AMC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $14.2M |
| Q1 2026 | $12.8M |
| Q4 2025 | — |
| Q4 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
OPRA spent $27M buying back its own shares over the past year, after none the year before.
AMC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 9.2x | High |
| Q4 2025 | 12.2x | High |
| Q3 2025 | 12.2x | High |
| Q2 2025 | 10.7x | High |
| Q1 2025 | 18.6x | High |
| Q4 2024 | 14.3x | High |
AMC's net debt is about 4.0 years of its operating earnings (EBITDA), down from 12 years a year ago.
OPRA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -0.8x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
| Q3 2024 | -1.0x | Net Cash |
OPRA has the edge over AMC on leverage, with a lower net debt burden relative to earnings.
AMC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 67.3 | Neutral |
| Stochastic | 65.4 | Neutral |
AMC's weekly RSI is 67 (neutral) and its Stochastic is 65 (neutral).
OPRA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 9.3 | Oversold |
OPRA's weekly RSI is 40 (neutral) and its Stochastic is 9 (oversold).
AMC PE vs Communication Services Sector
AMC has no meaningful PE right now: it lost money over the past year.
OPRA PE vs Communication Services Sector
| Metric | OPRA | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 16x | 31% below |
| PE % | 25 | 26 | 1 pt below |
OPRA is trading at 11x earnings, a 31% discount to the Communication Services sector's median of 16x, though its recent earnings include one-off gains.
AMC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.01 | 11% above |
| 20 week MA | $2.64 | 27% above |
| 50 week MA | $2.01 | 66% above |
| 100 week MA | $2.53 | 32% above |
| 200 week MA | $10.9 | 69% below |
AMC has the edge over OPRA on trend strength, trading above more of its moving averages.
OPRA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $16.7 | 6.6% below |
| 20 week MA | $18.2 | 14% below |
| 50 week MA | $16.6 | 5.6% below |
| 100 week MA | $16.9 | 7.6% below |
| 200 week MA | $15.3 | 2.4% above |
OPRA has fallen below most of its moving averages, though it's still 2.4% above its 200-week average.
AMC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $36.5 | $12.6 | -66% |
| 2021 | $12.6 | $142.6 | +1036% |
| 2022 | $142.6 | $44.0 | -69% |
| 2023 | $44.0 | $6.12 | -86% |
| 2024 | $6.12 | $4.00 | -35% |
| 2025 | $4.00 | $1.69 | -58% |
| 2026 YTD | $1.69 | $3.34 | +98% |
AMC has the edge over OPRA on returns for 2026, with the stronger performance.
OPRA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.44 | $8.49 | -10% |
| 2021 | $8.49 | $7.19 | -15% |
| 2022 | $7.19 | $5.98 | -17% |
| 2023 | $5.98 | $13.2 | +121% |
| 2024 | $13.2 | $19.0 | +43% |
| 2025 | $19.0 | $14.5 | -24% |
| 2026 YTD | $14.5 | $15.6 | +7.7% |
OPRA has finished lower in four of the last six years. It's up 7.7% so far in 2026.